down arrow

Global Medical REIT, Inc.

  • Market Cap: Micro Cap
  • Industry: Realty
  • ISIN: US37954A2042
USD
32.69
-0.62 (-1.86%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

32.6033.22

52 Week

29.0545.75
Valuation
Technical
Day's Volume

CASH

29.13 k

Shareholding (Mar 2025)

FII

5.64%

Held by 82 FIIs

DII

63.66%

Held by 37 DIIs

Promoter

0.00%

How big is Global Medical REIT, Inc.?

22-Jun-2025

As of Jun 18, Global Medical REIT, Inc. has a market capitalization of 451.94 million, with net sales of 154.28 million and a net profit of 8.12 million over the last four quarters. The company's total assets are reported at 1,256.49 million, with shareholder's funds of 534.13 million.

Market Cap: As of Jun 18, Global Medical REIT, Inc. has a market capitalization of 451.94 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the company reported net sales of 154.28 million and a net profit of 8.12 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company's shareholder's funds amounted to 534.13 million, while total assets were reported at 1,256.49 million.

Read More

What does Global Medical REIT, Inc. do?

22-Jun-2025

Global Medical REIT, Inc. acquires and leases licensed healthcare facilities to clinical operators. It has a market cap of $451.94 million, with recent net sales of $38 million and a net profit of $4 million.

Overview: <BR>Global Medical REIT, Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and leasing these facilities to clinical operators, operating within the Realty industry and classified as a Micro Cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 38 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 4 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 451.94 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 48.00 <BR>Dividend Yield: 3.11% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: 1.86% <BR>Price to Book: 0.87<BR><BR>Contact Details: <BR>Address: 2 Bethesda Metro Ctr Ste 440, BETHESDA MD: 20814-5333 <BR>Tel: 1 202 5246851 <BR>Website: http://www.globalmedicalreit.com/

Read More

Who are in the management team of Global Medical REIT, Inc.?

22-Jun-2025

As of March 2022, the management team of Global Medical REIT, Inc. includes Mr. Jeffrey Busch as Chairman, President, and CEO, with Ms. Huiqi Zhang and Mr. Jingguo Zhang as Directors, and Mr. Henry Cole, Ms. Paula Crowley, and Dr. Matthew Cypher as Independent Directors.

As of March 2022, the management team of Global Medical REIT, Inc. includes Mr. Jeffrey Busch, who serves as the Chairman of the Board, President, and Chief Executive Officer. Additionally, the Board of Directors features Ms. Huiqi Zhang and Mr. Jingguo Zhang as Directors, along with Mr. Henry Cole, Ms. Paula Crowley, and Dr. Matthew Cypher, who are all Independent Directors.

Read More

Is Global Medical REIT, Inc. overvalued or undervalued?

20-Sep-2025

As of August 3, 2021, Global Medical REIT, Inc. is considered very attractive due to its undervaluation indicated by a Price to Book Value of 0.89 and an EV to EBITDA ratio of 4.35, despite a higher P/E ratio of 48 compared to peers, and while it has underperformed the S&P 500 over the long term, it recently showed a potential turnaround with a 1-month return of 16.07%.

As of 3 August 2021, the valuation grade for Global Medical REIT, Inc. moved from risky to very attractive, indicating a significant improvement in its investment appeal. The company appears undervalued, particularly when considering its Price to Book Value of 0.89 and an EV to EBITDA ratio of 4.35, which are favorable compared to its peers. Additionally, the P/E ratio stands at 48, which is higher than the peer average of approximately 46.20 for similar companies like Armada Hoffler Properties, Inc. and New York Mortgage Trust, Inc., both of which also have attractive valuations.<BR><BR>In terms of peer comparison, Global Medical REIT, Inc. has a lower EV to EBITDA than Brandywine Realty Trust, which is at 2.49, suggesting it may be undervalued relative to its earnings potential. Despite a challenging return profile over longer periods, where it has underperformed the S&P 500 (with a 1-year return of -23.77% versus 17.14% for the index), its recent 1-month return of 16.07% compared to the S&P 500's 2.33% indicates a potential turnaround.

Read More

Is Global Medical REIT, Inc. technically bullish or bearish?

20-Sep-2025

As of August 11, 2025, Global Medical REIT, Inc. shows a mildly bearish trend with mixed signals from technical indicators, having outperformed the S&P 500 in the short term but significantly underperformed over the past year.

As of 11 August 2025, the technical trend for Global Medical REIT, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish trend, while the weekly MACD and KST show mildly bullish signals. The Bollinger Bands on a weekly basis are bullish, but monthly indicators remain bearish. Overall, the mixed signals suggest caution.<BR><BR>In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 1.18% and 16.07% respectively, but it has significantly underperformed over the longer term, with a 1-year return of -23.77% compared to the S&P 500's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Negative results in Jun 25

  • PRE-TAX PROFIT(Q) At USD 0.58 MM has Fallen at -76.15%
  • NET PROFIT(Q) At USD 0.66 MM has Fallen at -72.82%
  • DEBT-EQUITY RATIO (HY) Highest at 143.66 %
2

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Realty

stock-summary
Market cap

USD 554 Million (Micro Cap)

stock-summary
P/E

48.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4.35%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

2.38%

stock-summary
Price to Book

1.10

Revenue and Profits:
Net Sales:
41 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.4%
0%
-13.4%
6 Months
3.61%
0%
3.61%
1 Year
-25.37%
0%
-25.37%
2 Years
-37.13%
0%
-37.13%
3 Years
220.49%
0%
220.49%
4 Years
100.31%
0%
100.31%
5 Years
129.89%
0%
129.89%

Global Medical REIT, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Global Medical REIT Hits New 52-Week Low at $30.03

Global Medical REIT Hits New 52-Week Low at $30.03

Global Medical REIT, Inc. recently hit a 52-week low, despite a strong one-year performance significantly exceeding the S&P 500. The company has shown robust long-term growth in operating profits and net sales, although recent quarterly results indicate declines in pre-tax and net profits. Institutional holdings remain high, suggesting investor confidence.

Read More
Global Medical REIT Hits 52-Week Low at $30.09 Amid Profit Declines

Global Medical REIT Hits 52-Week Low at $30.09 Amid Profit Declines

Global Medical REIT, Inc. has reached a new 52-week low, reflecting recent volatility despite a strong one-year performance. The company, with a market cap of USD 554 million, faces challenges with declining profits but shows long-term growth potential and robust institutional holdings, indicating confidence in its fundamentals.

Read More
Global Medical REIT Forms Golden Cross, Signals Potential Bullish Breakout

Global Medical REIT Forms Golden Cross, Signals Potential Bullish Breakout

Global Medical REIT, Inc. has recently achieved a Golden Cross, indicating a potential shift in market momentum. The stock has demonstrated impressive performance, with a significant one-day increase and a substantial year-over-year surge. Technical indicators suggest a bullish outlook, despite some bearish signals on the RSI.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
13.90%
EBIT Growth (5y)
18.16%
EBIT to Interest (avg)
1.53
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
6,829.27%
Pledged Shares
0
Institutional Holding
75.96%
ROCE (avg)
7.78%
ROE (avg)
2.27%
Valuation key factors
Factor
Value
P/E Ratio
48
Industry P/E
Price to Book Value
0.89
EV to EBIT
9.22
EV to EBITDA
4.35
EV to Capital Employed
0.89
EV to Sales
2.94
PEG Ratio
NA
Dividend Yield
3.04%
ROCE (Latest)
9.69%
ROE (Latest)
1.86%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Bearish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 61 Schemes (30.54%)

Foreign Institutions

Held by 82 Foreign Institutions (5.64%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 8.97% vs -2.82% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -83.78% vs 27.59% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "41.30",
          "val2": "37.90",
          "chgp": "8.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27.00",
          "val2": "26.70",
          "chgp": "1.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.30",
          "val2": "10.40",
          "chgp": "8.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.60",
          "val2": "3.70",
          "chgp": "-83.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "284.40%",
          "val2": "339.20%",
          "chgp": "-5.48%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -0.45% vs 14.38% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -69.12% vs 8.50% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "156.00",
          "val2": "156.70",
          "chgp": "-0.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "105.40",
          "val2": "111.70",
          "chgp": "-5.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "45.90",
          "val2": "46.50",
          "chgp": "-1.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.70",
          "val2": "-0.90",
          "chgp": "-88.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.70",
          "val2": "21.70",
          "chgp": "-69.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "321.10%",
          "val2": "341.80%",
          "chgp": "-2.07%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
41.30
37.90
8.97%
Operating Profit (PBDIT) excl Other Income
27.00
26.70
1.12%
Interest
11.30
10.40
8.65%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.60
3.70
-83.78%
Operating Profit Margin (Excl OI)
284.40%
339.20%
-5.48%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 8.97% vs -2.82% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -83.78% vs 27.59% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
156.00
156.70
-0.45%
Operating Profit (PBDIT) excl Other Income
105.40
111.70
-5.64%
Interest
45.90
46.50
-1.29%
Exceptional Items
-1.70
-0.90
-88.89%
Consolidate Net Profit
6.70
21.70
-69.12%
Operating Profit Margin (Excl OI)
321.10%
341.80%
-2.07%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -0.45% vs 14.38% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -69.12% vs 8.50% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Global Medical REIT, Inc. stock-summary
stock-summary
Global Medical REIT, Inc.
Realty
Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.
Company Coordinates stock-summary
Company Details
2 Bethesda Metro Ctr Ste 440 , BETHESDA MD : 20814-5333
stock-summary
Tel: 1 202 5246851
stock-summary
http://www.globalmedicalreit.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."